ID   EAA3_HUMAN              Reviewed;         524 AA.
AC   P43005; O75587; Q5VZ24; Q8N199; Q9UEW2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Excitatory amino acid transporter 3;
DE   AltName: Full=Excitatory amino-acid carrier 1;
DE   AltName: Full=Neuronal and epithelial glutamate transporter;
DE   AltName: Full=Sodium-dependent glutamate/aspartate transporter 3;
DE   AltName: Full=Solute carrier family 1 member 1;
GN   Name=SLC1A1; Synonyms=EAAC1, EAAT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7859077; DOI=10.1016/0006-8993(94)90819-2;
RA   Shashidharan P., Huntley G.W., Meyer T., Morrison J.H., Plaitakis A.;
RT   "Neuron-specific human glutamate transporter: molecular cloning,
RT   characterization and expression in human brain.";
RL   Brain Res. 662:245-250(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=7914198;
RA   Kanai Y., Stelzner M., Nussberger S., Khawaja S., Hebert S.C.,
RA   Smith C.P., Hediger M.A.;
RT   "The neuronal and epithelial human high affinity glutamate
RT   transporter. Insights into structure and mechanism of transport.";
RL   J. Biol. Chem. 269:20599-20606(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=7521911;
RA   Arriza J.L., Fairman W.A., Wendy A., Wadiche J.I., Murdoch G.H.,
RA   Kavanaugh M.P., Amara S.G.;
RT   "Functional comparisons of three glutamate transporter subtypes cloned
RT   from human motor cortex.";
RL   J. Neurosci. 14:5559-5569(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11317217; DOI=10.1038/sj.mp.4000806;
RA   Veenstra-VanderWeele J., Kim S.J., Gonen D., Hanna G.L.,
RA   Leventhal B.L., Cook E.H. Jr.;
RT   "Genomic organization of the SLC1A1/EAAC1 gene and mutation screening
RT   in early-onset obsessive-compulsive disorder.";
RL   Mol. Psychiatry 6:160-167(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RA   Yasuda-Kamatani Y.;
RT   "A glutamate transporter related to EAAT3 from human brain.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 268-446.
RC   TISSUE=Placenta;
RA   Rome S., Mertani H.C., Lee K.O., Lobie P.E., Tome D.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   INVOLVEMENT IN SCZD18.
RX   PubMed=21982423; DOI=10.1016/j.biopsych.2011.08.009;
RA   Melhem N., Middleton F., McFadden K., Klei L., Faraone S.V.,
RA   Vinogradov S., Tiobech J., Yano V., Kuartei S., Roeder K., Byerley W.,
RA   Devlin B., Myles-Worsley M.;
RT   "Copy number variants for schizophrenia and related psychotic
RT   disorders in Oceanic Palau: risk and transmission in extended
RT   pedigrees.";
RL   Biol. Psychiatry 70:1115-1121(2011).
RN   [10]
RP   INVOLVEMENT IN SCZD18.
RX   PubMed=23341099; DOI=10.1002/ajmg.b.32125;
RA   Myles-Worsley M., Tiobech J., Browning S.R., Korn J., Goodman S.,
RA   Gentile K., Melhem N., Byerley W., Faraone S.V., Middleton F.A.;
RT   "Deletion at the SLC1A1 glutamate transporter gene co-segregates with
RT   schizophrenia and bipolar schizoaffective disorder in a 5-generation
RT   family.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B:87-95(2013).
RN   [11]
RP   VARIANTS DCBXA ILE-395 DEL AND TRP-445, CHARACTERIZATION OF VARIANTS
RP   DCBXA ILE-395 DEL AND TRP-445, INVOLVEMENT IN DCBXA, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=21123949; DOI=10.1172/JCI44474;
RA   Bailey C.G., Ryan R.M., Thoeng A.D., Ng C., King K.,
RA   Vanslambrouck J.M., Auray-Blais C., Vandenberg R.J., Broer S.,
RA   Rasko J.E.;
RT   "Loss-of-function mutations in the glutamate transporter SLC1A1 cause
RT   human dicarboxylic aminoaciduria.";
RL   J. Clin. Invest. 121:446-453(2011).
CC   -!- FUNCTION: Transports L-glutamate, L- and D-aspartate and L-cystein
CC       (PubMed:21123949). Essential for terminating the postsynaptic
CC       action of glutamate by rapidly removing released glutamate from
CC       the synaptic cleft. Acts as a symport by cotransporting sodium.
CC       Negatively regulated by ARL6IP5 (By similarity).
CC       {ECO:0000250|UniProtKB:P51906, ECO:0000250|UniProtKB:P51907,
CC       ECO:0000269|PubMed:21123949}.
CC   -!- SUBUNIT: Interacts with ARL6IP5. {ECO:0000250|UniProtKB:P51906}.
CC   -!- INTERACTION:
CC       Q5T700:LDLRAD1; NbExp=3; IntAct=EBI-745376, EBI-10173166;
CC       Q99942:RNF5; NbExp=5; IntAct=EBI-745376, EBI-348482;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21123949};
CC       Multi-pass membrane protein. Apical cell membrane
CC       {ECO:0000269|PubMed:21123949}; Multi-pass membrane protein.
CC       Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested including
CC       liver, muscle, testis, ovary, retinoblastoma cell line, neurons
CC       and brain (in which there was dense expression in substantia
CC       nigra, red nucleus, hippocampus and in cerebral cortical layers).
CC       {ECO:0000269|PubMed:7521911, ECO:0000269|PubMed:7859077,
CC       ECO:0000269|PubMed:7914198}.
CC   -!- PTM: Glycosylated.
CC   -!- DISEASE: Dicarboxylic aminoaciduria (DCBXA) [MIM:222730]: An
CC       autosomal recessive disorder characterized by abnormal excretion
CC       of urinary glutamate and aspartate, resulting from the incomplete
CC       reabsorption of anionic amino acids from the glomerular filtrate
CC       in the kidney. It can be associated with mental retardation.
CC       {ECO:0000269|PubMed:21123949}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Schizophrenia 18 (SCZD18) [MIM:615232]: A complex,
CC       multifactorial psychotic disorder or group of disorders
CC       characterized by disturbances in the form and content of thought
CC       (e.g. delusions, hallucinations), in mood (e.g. inappropriate
CC       affect), in sense of self and relationship to the external world
CC       (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g
CC       bizarre or apparently purposeless behavior). Although it affects
CC       emotions, it is distinguished from mood disorders in which such
CC       disturbances are primary. Similarly, there may be mild impairment
CC       of cognitive function, and it is distinguished from the dementias
CC       in which disturbed cognitive function is considered primary. Some
CC       patients manifest schizophrenic as well as bipolar disorder
CC       symptoms and are often given the diagnosis of schizoaffective
CC       disorder. {ECO:0000269|PubMed:21982423,
CC       ECO:0000269|PubMed:23341099}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry. A deletion at the chromosome 9p24.2 locus, including
CC       SLC1A1, has been identified in patients with psychotic disorders
CC       (PubMed:21982423). This 84 kb deletion is immediately upstream of
CC       the SLC1A1 gene in a regulatory region that contains the full
CC       native promoter sequence, extends through exon 1 of the SLC1A1
CC       mRNA, co-segregates with disease in an extended 5-generation
CC       pedigree and increases disease risk more than 18-fold for family
CC       members (PubMed:23341099). {ECO:0000269|PubMed:21982423,
CC       ECO:0000269|PubMed:23341099}.
CC   -!- SIMILARITY: Belongs to the dicarboxylate/amino acid:cation
CC       symporter (DAACS) (TC 2.A.23) family. SLC1A1 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U08989; AAA68628.1; -; mRNA.
DR   EMBL; U06469; AAA53215.1; -; mRNA.
DR   EMBL; U03506; AAA50430.1; -; mRNA.
DR   EMBL; AF074911; AAC27511.3; -; Genomic_DNA.
DR   EMBL; AF143773; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074903; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074904; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074905; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074906; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074907; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074908; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074909; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AF074910; AAC27511.3; JOINED; Genomic_DNA.
DR   EMBL; AB008536; BAB83767.1; -; mRNA.
DR   EMBL; AL162587; CAH71965.1; -; Genomic_DNA.
DR   EMBL; AL136231; CAH71965.1; JOINED; Genomic_DNA.
DR   EMBL; AL136231; CAI41264.1; -; Genomic_DNA.
DR   EMBL; AL162587; CAI41264.1; JOINED; Genomic_DNA.
DR   EMBL; BC033040; AAH33040.1; -; mRNA.
DR   EMBL; AF037982; AAC25029.1; -; mRNA.
DR   CCDS; CCDS6452.1; -.
DR   PIR; A54856; A54856.
DR   PIR; I38433; I38433.
DR   PIR; I38560; I38560.
DR   RefSeq; NP_004161.4; NM_004170.5.
DR   UniGene; Hs.444915; -.
DR   ProteinModelPortal; P43005; -.
DR   BioGrid; 112396; 33.
DR   IntAct; P43005; 3.
DR   STRING; 9606.ENSP00000262352; -.
DR   BindingDB; P43005; -.
DR   ChEMBL; CHEMBL2721; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00230; Pregabalin.
DR   GuidetoPHARMACOLOGY; 870; -.
DR   TCDB; 2.A.23.2.3; the dicarboxylate/amino acid:cation (na(+) or h(+)) symporter (daacs) family.
DR   iPTMnet; P43005; -.
DR   PhosphoSitePlus; P43005; -.
DR   BioMuta; SLC1A1; -.
DR   DMDM; 1352332; -.
DR   EPD; P43005; -.
DR   MaxQB; P43005; -.
DR   PaxDb; P43005; -.
DR   PeptideAtlas; P43005; -.
DR   PRIDE; P43005; -.
DR   DNASU; 6505; -.
DR   Ensembl; ENST00000262352; ENSP00000262352; ENSG00000106688.
DR   GeneID; 6505; -.
DR   KEGG; hsa:6505; -.
DR   UCSC; uc003zij.3; human.
DR   CTD; 6505; -.
DR   DisGeNET; 6505; -.
DR   GeneCards; SLC1A1; -.
DR   HGNC; HGNC:10939; SLC1A1.
DR   HPA; CAB015466; -.
DR   HPA; HPA020086; -.
DR   MalaCards; SLC1A1; -.
DR   MIM; 133550; gene.
DR   MIM; 222730; phenotype.
DR   MIM; 615232; phenotype.
DR   neXtProt; NX_P43005; -.
DR   OpenTargets; ENSG00000106688; -.
DR   Orphanet; 2195; Dicarboxylic aminoaciduria.
DR   Orphanet; 3140; Schizophrenia.
DR   PharmGKB; PA35826; -.
DR   eggNOG; KOG3787; Eukaryota.
DR   eggNOG; COG1301; LUCA.
DR   GeneTree; ENSGT00760000119117; -.
DR   HOGENOM; HOG000208776; -.
DR   HOVERGEN; HBG000080; -.
DR   InParanoid; P43005; -.
DR   KO; K05612; -.
DR   OMA; CEKKSYV; -.
DR   OrthoDB; EOG091G0UCE; -.
DR   PhylomeDB; P43005; -.
DR   TreeFam; TF315206; -.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-425393; Transport of inorganic cations/anions and amino acids/oligopeptides.
DR   ChiTaRS; SLC1A1; human.
DR   GeneWiki; SLC1A1; -.
DR   GenomeRNAi; 6505; -.
DR   PRO; PR:P43005; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106688; -.
DR   CleanEx; HS_SLC1A1; -.
DR   ExpressionAtlas; P43005; baseline and differential.
DR   Genevisible; P43005; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0033229; F:cysteine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0016595; F:glutamate binding; IEA:Ensembl.
DR   GO; GO:0015501; F:glutamate:sodium symporter activity; IEA:Ensembl.
DR   GO; GO:0005314; F:high-affinity glutamate transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0042883; P:cysteine transport; IDA:UniProtKB.
DR   GO; GO:0070779; P:D-aspartate import; IDA:UniProtKB.
DR   GO; GO:0014047; P:glutamate secretion; TAS:Reactome.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0051938; P:L-glutamate import; IDA:UniProtKB.
DR   GO; GO:0089711; P:L-glutamate transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0010460; P:positive regulation of heart rate; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   Gene3D; 1.10.3860.10; -; 1.
DR   InterPro; IPR001991; Na-dicarboxylate_symporter.
DR   InterPro; IPR018107; Na-dicarboxylate_symporter_CS.
DR   Pfam; PF00375; SDF; 1.
DR   PRINTS; PR00173; EDTRNSPORT.
DR   SUPFAM; SSF118215; SSF118215; 2.
DR   PROSITE; PS00713; NA_DICARBOXYL_SYMP_1; 1.
DR   PROSITE; PS00714; NA_DICARBOXYL_SYMP_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome;
KW   Schizophrenia; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    524       Excitatory amino acid transporter 3.
FT                                /FTId=PRO_0000202065.
FT   TOPO_DOM      1     18       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     19     38       Helical. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   TRANSMEM     94    114       Helical. {ECO:0000255}.
FT   TOPO_DOM    115    209       Extracellular. {ECO:0000255}.
FT   TRANSMEM    210    229       Helical. {ECO:0000255}.
FT   TRANSMEM    254    273       Helical. {ECO:0000255}.
FT   TRANSMEM    290    309       Helical. {ECO:0000255}.
FT   TRANSMEM    316    335       Helical. {ECO:0000255}.
FT   TRANSMEM    362    381       Helical. {ECO:0000255}.
FT   TRANSMEM    392    411       Helical. {ECO:0000255}.
FT   TRANSMEM    420    439       Helical. {ECO:0000255}.
FT   MOD_RES     517    517       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51906}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51906}.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    178    178       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      27     27       A -> G (in dbSNP:rs2229885).
FT                                /FTId=VAR_023309.
FT   VARIANT      50     50       F -> Y (in dbSNP:rs2228621).
FT                                /FTId=VAR_023308.
FT   VARIANT     395    395       Missing (in DCBXA; inhibits L-glutamate
FT                                and L-cysteine transport activities).
FT                                {ECO:0000269|PubMed:21123949}.
FT                                /FTId=VAR_071953.
FT   VARIANT     445    445       R -> W (in DCBXA; reduces L-glutamate and
FT                                L-cysteine transport activities; reduces
FT                                cell membrane expression;
FT                                dbSNP:rs587777696).
FT                                {ECO:0000269|PubMed:21123949}.
FT                                /FTId=VAR_071954.
FT   CONFLICT     10     10       E -> PS (in Ref. 3; AAA50430).
FT                                {ECO:0000305}.
FT   CONFLICT     92     92       L -> V (in Ref. 7; AAH33040).
FT                                {ECO:0000305}.
FT   CONFLICT     94     94       A -> V (in Ref. 1; AAA68628 and 4;
FT                                AAC27511). {ECO:0000305}.
FT   CONFLICT     96     96       V -> L (in Ref. 2; AAA53215).
FT                                {ECO:0000305}.
FT   CONFLICT    170    170       K -> N (in Ref. 2; AAA53215).
FT                                {ECO:0000305}.
FT   CONFLICT    172    172       P -> A (in Ref. 2; AAA53215).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       L -> H (in Ref. 2; AAA53215).
FT                                {ECO:0000305}.
FT   CONFLICT    280    280       R -> A (in Ref. 1; AAA68628).
FT                                {ECO:0000305}.
FT   CONFLICT    376    376       V -> G (in Ref. 8; AAC25029).
FT                                {ECO:0000305}.
SQ   SEQUENCE   524 AA;  57100 MW;  FC6244ADC9EA228F CRC64;
     MGKPARKGCE WKRFLKNNWV LLSTVAAVVL GITTGVLVRE HSNLSTLEKF YFAFPGEILM
     RMLKLIILPL IISSMITGVA ALDSNVSGKI GLRAVVYYFC TTLIAVILGI VLVVSIKPGV
     TQKVGEIART GSTPEVSTVD AMLDLIRNMF PENLVQACFQ QYKTKREEVK PPSDPEMNMT
     EESFTAVMTT AISKNKTKEY KIVGMYSDGI NVLGLIVFCL VFGLVIGKMG EKGQILVDFF
     NALSDATMKI VQIIMCYMPL GILFLIAGKI IEVEDWEIFR KLGLYMATVL TGLAIHSIVI
     LPLIYFIVVR KNPFRFAMGM AQALLTALMI SSSSATLPVT FRCAEENNQV DKRITRFVLP
     VGATINMDGT ALYEAVAAVF IAQLNDLDLG IGQIITISIT ATSASIGAAG VPQAGLVTMV
     IVLSAVGLPA EDVTLIIAVD WLLDRFRTMV NVLGDAFGTG IVEKLSKKEL EQMDVSSEVN
     IVNPFALEST ILDNEDSDTK KSYVNGGFAV DKSDTISFTQ TSQF
//
